norcantharidin has been researched along with Giant Cell Tumor of Bone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, J; Huang, G; Shi, J; Wang, S; Wei, Y; Wu, J; Xia, J | 1 |
1 other study(ies) available for norcantharidin and Giant Cell Tumor of Bone
| Article | Year |
|---|---|
Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion Molecules; Cell Cycle; Cell Movement; Cell Proliferation; Giant Cell Tumor of Bone; Humans; Membrane Proteins; MicroRNAs; Primary Cell Culture; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Signal Transduction; Stromal Cells; Tumor Cells, Cultured | 2018 |